Mazor Robotics (NASDAQ: MZOR) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.
Risk and Volatility
Mazor Robotics has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500.
This table compares Mazor Robotics and Merit Medical Systems’ revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Mazor Robotics||$64.95 million||23.16||-$12.41 million||($0.50)||-114.28|
|Merit Medical Systems||$727.85 million||3.48||$27.52 million||$1.28||39.22|
Merit Medical Systems has higher revenue and earnings than Mazor Robotics. Mazor Robotics is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.
This table compares Mazor Robotics and Merit Medical Systems’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Merit Medical Systems||2.37%||10.01%||6.01%|
Insider & Institutional Ownership
23.9% of Mazor Robotics shares are owned by institutional investors. Comparatively, 92.3% of Merit Medical Systems shares are owned by institutional investors. 5.0% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
This is a breakdown of current recommendations for Mazor Robotics and Merit Medical Systems, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Merit Medical Systems||0||0||12||0||3.00|
Mazor Robotics presently has a consensus price target of $55.50, suggesting a potential downside of 2.87%. Merit Medical Systems has a consensus price target of $51.00, suggesting a potential upside of 1.59%. Given Merit Medical Systems’ stronger consensus rating and higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than Mazor Robotics.
Merit Medical Systems beats Mazor Robotics on 13 of the 14 factors compared between the two stocks.
About Mazor Robotics
Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures. The company's surgical robotic-guidance systems and complementary products are used to conduct spine and brain procedures in an accurate and secure manner. It also offers Mazor X, a renaissance system and its accessories are used in spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision, and cement augmentations. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.
About Merit Medical Systems
Merit Medical Systems, Inc. designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management. The company also offers cardiovascular and critical care products comprising infection prevention and safety, and fluid management and monitoring devices. In addition, it provides interventional oncology and spine products, such as vertebral compression fractures; tumor ablation systems; inflation syringes; microspheres for treating hypervascularized tumors and liver cancer; polyvinyl alcohol particles to treat hypervascularized tumors; and microcatheters for the controlled and selective infusion of diagnostic, embolic, or therapeutic agents into vessels. Further, the company offers endoscopy products, such as non-vascular stents, esophageal stents, biliary stent systems, esophageal balloon dilators, inflation devices, and guide wires; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; and microelectromechanical systems sensor components. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.